Paradigm Biopharmaceuticals Ltd Investor Webinar Transcript
Thank you for standing by, and welcome to the Paradigm Biopharmaceuticals Top-line Data Investor Webinar, discussing the announcement lodged with the ASX earlier this morning. Firstly, an apology for the short notice between the announcement lodgment and this session. We are awaiting approval from the ASX to have the announcement lodged.
And for anyone who has missed a live session now, this is being recorded. And the replay will be available very soon after the end of the webinar. All participants today are in listen-only mode. There will be a slide presentation lasting for approximately 20 to 25 minutes.
Please note that today's session is designed to give an overview of the new data announcement. And we would ask for any questions to be referred to the Investor Relations at paradigmbiopharma.com e-mail address, which can be found at the bottom of all announcements. And these will be responded to after the webinar.
In terms of introductions appearing on behalf of Paradigm today, we have CEO, Marco Polizzi; Chief Medical Officer, Dr. Donna Skerrett; and Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |